Document Type : Original Article

Authors

1 Department of Nephrology, Zabol University of Medical Sciences, Zabol, Iran

2 Department of Nephrology, Zahedan University of Medical Sciences, Zahedan, Iran

3 Department of Internal Medicine, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

10.22034/ijabbr.2021.537924.1366

Abstract

Background: Vitamin D, especially calcitriol (its active metabolite), increases gastrointestinal calcium absorption. Because urinary calcium excretion is associated with calcium absorption in the gastrointestinal tract; vitamin D metabolites could theoretically cause hypercalciuria. The aim of this study was to investigate the relationship between treatment and vitamin D supplementation on the rate of hypercalciuria in patients.
Method: In the present double-blind randomized clinical trial, 90 patients (male-female) with urinary stones and serum vitamin D levels less than 30 ng/mL were evaluated. Patients were randomLy divided into two groups of 45 patients. One group was given 50,000 units of oral vitamin D weekly for up to 8 weeks. For the other group, the drug was given as a placebo for up to 8 weeks. Sampling was performed one month after the end of treatment. The data garnered from hospital records were inserted into SPSS software for analysis.
Results: In the present study, the mean age of the subjects was 39.78 years. Also, out of 90 patients, 52 were male and 38 were female. Blood PTH levels decreased significantly after treatment in vitamin D group (P <0.001). Also, serum levels of vitamin D in this group showed a significant increase (P <0.001). However, in this study urinary calcium levels after treatment did not show significant changes (P = 0.680).
Conclusion: The present study showed that in people with a history of kidney stones, taking vitamin D supplement alone for people with lower than standard serum levels of vitamin D did not show any significant difference in calcification. As a result, the therapeutic dose of this drug is recommended in patients with kidney stones according to the condition.

Graphical Abstract

Evaluation of Relationship between Vitamin D Supplementation Treatment and Hypercalciuria in Patients with Kidney Stones

Keywords

Main Subjects

  1. Pulipati S, Babu P S, Narasu M L, Anusha N. (2017). An overview on urinary tract infections and effective natural remedies. J. Med. Plants, 5: 50-56
  2. Fiorentino M, Pesce F, Schena A, Simone S, Castellano G, Gesualdo L. (2019). Updates on urinary tract infections in kidney transplantation. Journal of nephrology: 1-11. https://doi.org/10.1007/s40620-019-00585-3
  3. Srivastava T, Thiagarajan G, Alon U S, Sharma R, El-Meanawy A, McCarthy E T, Savin V J, Sharma M. (2017). Role of biomechanical forces in hyperfiltration-mediated glomerular injury in congenital anomalies of the kidney and urinary tract. Nephrology dialysis transplantation, 32(5): 759-765 https://doi.org/10.1093/ndt/gfw430
  4. Khan F, Haider M F, Singh M K, Sharma P, Kumar T, Neda E N. (2019). A comprehensive review on kidney stones, its diagnosis and treatment with allopathic and ayurvedic medicines. Urol Nephrol Open Access J, 7(4): 69-74. https://doi.org/10.15406/unoaj.2019.07.00247
  5. Simforosh N, Noralizadeh A, Soltani M H. (2020). General urology (Vol. 3). Shahid Beheshti University of Medical Sciences, Tehran: Teimourzadeh Press. 535 Pages
  6. Daudon M, Frochot V, Bazin D, Jungers P. (2018). Drug-induced kidney stones and crystalline nephropathy: pathophysiology, prevention and treatment. Drugs, 78(2): 163-201. https://doi.org/10.1007/s40265-017-0853-7
  7. Coe F L, Worcester E M, Evan A P. (2016). Idiopathic hypercalciuria and formation of calcium renal stones. Nature Reviews Nephrology, 12(9): 519-533. https://doi.org/10.1038/nrneph.2016.101
  8. Perez-Suarez G, Yanes M I L, de Basoa M C M F, Almeida E S, Nieto V M G. (2021). Evolution of bone mineral density in patients with idiopathic hypercalciuria: a 20-year longitudinal study. Pediatric Nephrology, 36(3): 661-667. https://doi.org/10.1007/s00467-020-04754-6
  9. Fleet J C. (2017). The role of vitamin D in the endocrinology controlling calcium homeostasis. Molecular and cellular endocrinology, 453: 36-45. https://doi.org/10.1016/j.mce.2017.04.008
  10. Hoenderop J G, Nilius B, Bindels R J. (2005). Calcium absorption across epithelia. Physiological reviews, 85(1): 373-422. https://doi.org/10.1152/physrev.00003.2004
  11. Gkika D, Hsu Y-J, Van Der Kemp A W, Christakos S, Bindels R J, Hoenderop J G. (2006). Critical role of the epithelial Ca2+ channel TRPV5 in active Ca2+ reabsorption as revealed by TRPV5/calbindin-D28K knockout mice. Journal of the American Society of Nephrology, 17(11): 3020-3027. https://doi.org/10.1681/ASN.2006060676
  12. Thacher T D, Clarke B L. (2011). Vitamin D insufficiency. Paper presented at the Mayo Clinic Proceedings. https://doi.org/10.4065/mcp.2010.0567
  13. Schulster M L, Goldfarb D S. (2020). Vitamin D and kidney stones. Urology, 139: 1-7. https://doi.org/10.1016/j.urology.2020.01.030
  14. Letavernier E, Daudon M. (2018). Vitamin D, hypercalciuria and kidney stones. Nutrients, 10(3): 366. https://doi.org/10.3390/nu10030366
  15. Wilz D R, Gray R W, Dominguez J H, Lemann Jr J. (1979). Plasma 1, 25-(OH) 2-vitamin D concentrations and net intestinal calcium, phosphate, and magnesium absorption in humans. The American journal of clinical nutrition, 32(10): 2052-2060. https://doi.org/10.1093/ajcn/32.10.2052
  16. Broadus A E, Horst R L, Lang R, Littledike E T, Rasmussen H. (1980). The importance of circulating 1, 25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism. New England Journal of Medicine, 302(8): 421-426. https://doi.org/10.1056/NEJM198002213020801
  17. Melo T L, Esper P L G, Zambrano L I, Ormanji M S, Rodrigues F G, Heilberg I P. (2020). Expression of vitamin D receptor, CYP27B1 and CYP24A1 hydroxylases and 1, 25-dihydroxyvitamin D 3 levels in stone formers. Urolithiasis, 48(1): 19-26. https://doi.org/10.1007/s00240-019-01163-9
  18. Ferraro P M, Taylor E N, Gambaro G, Curhan G C. (2017). Vitamin D intake and the risk of incident kidney stones. The Journal of urology, 197(2): 405-410. https://doi.org/10.1016/j.juro.2016.08.084
  19. Ganji M R, Shafii Z, Hakemi M S. (2019). Vitamin D supplementation and risk of hypercalciuria in stone formers. Iranian journal of kidney diseases, 13(1): 27-31.
  20. Qaseem A, Dallas P, Forciea M A, Starkey M, Denberg T D. (2014). Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 161(9): 659-667. https://doi.org/10.7326/M13-2908
  21. Leaf D E, Korets R, Taylor E N, Tang J, Asplin J R, Goldfarb D S, Gupta M, Curhan G C. (2012). Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers. Clinical Journal of the American Society of Nephrology, 7(5): 829-834. https://doi.org/10.2215/CJN.11331111
  22. Gallagher J C, Smith L M, Yalamanchili V. (2014). Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older women. Menopause (New York, NY), 21(11): 1173. PMCID: PMC4209182; NIHMSID: NIHMS608543; PMID: 24937025; https://doi.org/10.1097/GME.0000000000000270
  23. Zwart S R, Parsons H, KimLin M, Innis S M, Locke J P, Smith S M. (2013). A 250 μg/week dose of vitamin D was as effective as a 50 μg/d dose in healthy adults, but a regimen of four weekly followed by monthly doses of 1250 μg raised the risk of hypercalciuria. British journal of nutrition, 110(10): 1866-1872. https://doi.org/10.1017/S000711451300113X
  24. Ramos M F d P, Santana L G d, Rasvickas C V, Teixeira V d P C, Schor N. (2014). Effect of vitamin D3 overdose and calcium supplementation in experimental nephrolithiasis model. Brazilian Journal of Nephrology, 36: 132-138. https://doi.org/10.5935/0101-2800.20140022
  25. Courbebaisse M, Thervet E, Souberbielle J C, Zuber J, Eladari D, Martinez F, Mamzer-Bruneel M-F, Urena P, Legendre C, Friedlander G. (2009). Effects of vitamin D supplementation on the calcium–phosphate balance in renal transplant patients. Kidney international, 75(6): 646-651. https://doi.org/10.1038/ki.2008.549
  26. Goussous R, Song L, Dallal G E, Dawson-Hughes B. (2005). Lack of effect of calcium intake on the 25-hydroxyvitamin D response to oral vitamin D3. The Journal of Clinical Endocrinology & Metabolism, 90(2): 707-711. https://doi.org/10.1210/jc.2004-1380
  27. Thiagarajan N, Kumar C D, Sahoo J, Krishnamurthy S. (2019). Effect of vitamin D and calcium supplementation on bone mineral content in children with thalassemia. Indian Pediatr, 56(4): 307-310.
  28. Weber J, Prusseit J, Staufenbiel R. (2021). Effects of calcium supplementation, incomplete milking, and vitamin D3 injection on serum total calcium concentration during the first 24 hours after parturition in dairy cows fed an anionic diet during late gestation. American Journal of Veterinary Research, 82(8): 634-643. https://doi.org/10.2460/ajvr.82.8.634.